ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,510Medicare Part D Prescriptions Filled, Including Refills

Rank: 18 out of 198

$965K Total Retail Price of All Prescriptions

Rank: 9 out of 198

654 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 654 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

16% of this provider’s 654 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 13,477 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
FUROSEMIDE 525 481 1 5
WARFARIN SODIUM 484 427 2 7
AMLODIPINE BESYLATE 478 460 3 4
OMEPRAZOLE 443 381 4 3
HYDROCODONE-ACETAMINOPHEN 443 322 S3 4 8
POTASSIUM CHLORIDE 420 396 6 9
METOPROLOL TARTRATE 386 379 7 10
LEVOTHYROXINE SODIUM 370 347 8 1
SIMVASTATIN 309 276 9 2
ATORVASTATIN CALCIUM 299 258 10 12
DONEPEZIL HCL 289 289 11 28
LISINOPRIL 275 248 12 6
ALENDRONATE SODIUM 260 258 13 21
METOPROLOL SUCCINATE 251 213 14 11
METFORMIN HCL 235 214 15 13
ZOLPIDEM TARTRATE 207 132 16 22
MELOXICAM 205 181 17 30
CITALOPRAM HBR 204 173 18 20
GLIMEPIRIDE 164 162 19 35
NAMENDA 163 163 20 33
CRESTOR 160 157 21 26
PREDNISONE 158 116 22 29
DIOVAN 157 157 23 34
LOSARTAN POTASSIUM 145 141 24 18
CELEBREX 144 143 25 59
CLOPIDOGREL 142 123 26 42
CEFUROXIME 136 111 27 178
ADVAIR DISKUS 127 122 28 47
PANTOPRAZOLE SODIUM 125 97 29 31
VESICARE 120 109 30 77
ALLOPURINOL 119 102 31 23
PLAVIX 115 107 32 66
AZITHROMYCIN 108 87 33 56
GABAPENTIN 108 70 33 14
DIOVAN HCT 102 102 35 88
CARVEDILOL 101 86 36 24
PROAIR HFA 99 52 37 80
ESCITALOPRAM OXALATE 99 85 37 53
CLONIDINE HCL 97 96 39 52
TRAMADOL HCL 96 90 40 15
TAMSULOSIN HCL 95 90 41 27
CYMBALTA 92 70 42 48
LANTUS SOLOSTAR 88 74 43 85
ATENOLOL 87 74 44 17
POLYETHYLENE GLYCOL 3350 87 74 44 41
LEVOFLOXACIN 84 69 46 81
DILTIAZEM ER 81 76 47 98
SERTRALINE HCL 80 73 48 25
HYDROCHLOROTHIAZIDE 79 68 49 16
AMLODIPINE BESYLATE-BENAZEPRIL 78 50 50 99
MIRTAZAPINE 77 70 51 44
LISINOPRIL-HYDROCHLOROTHIAZIDE 76 74 52 38
COMBIVENT 76 69 52 210
CIPROFLOXACIN HCL 74 68 54 55
DILTIAZEM 24HR CD 73 70 55 126
LANTUS 71 64 56 46
SPIRONOLACTONE 69 68 57 37
DIGOXIN 69 69 57 43
FLUTICASONE PROPIONATE 68 42 59 39
NEXIUM 68 66 59 40
VERAPAMIL ER 65 61 61 117
PEN NEEDLE 65 49 61 114
AMITRIPTYLINE HCL 65 59 R 61 69
ZOSTAVAX 62 57 64 169
CARBIDOPA-LEVODOPA 61 61 65 71
JANUVIA 59 59 66 86
INSULIN SYRINGE 59 43 66 95
CYCLOBENZAPRINE HCL 58 42 R 68 67
AMIODARONE HCL 57 57 69 119
TRAMADOL HCL-ACETAMINOPHEN 57 55 69 185
QUETIAPINE FUMARATE 56 54 71 76
PRISTIQ ER 55 22 72 273
MECLIZINE HCL 55 54 72 129
DIPHENOXYLATE-ATROPINE 53 53 74 191
MIDODRINE HCL 52 21 75 232
PRAMIPEXOLE DIHYDROCHLORIDE 51 45 76 157
RAMIPRIL 51 48 76 72
FAMOTIDINE 51 41 76 57
PRAVASTATIN SODIUM 50 41 79 19
RISPERIDONE 50 36 79 82
EVISTA 50 49 79 104
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 25, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.